Product Details for NDA 020343
PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER (MILRINONE LACTATE)
EQ 10MG BASE/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
EQ 15MG BASE/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
EQ 10MG BASE/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: MILRINONE LACTATE
Proprietary Name: PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 10MG BASE/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020343
Product Number: 001
Approval Date: Aug 9, 1994
Applicant Holder Full Name: SANOFI AVENTIS US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER (MILRINONE LACTATE)
Proprietary Name: PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 10MG BASE/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020343
Product Number: 001
Approval Date: Aug 9, 1994
Applicant Holder Full Name: SANOFI AVENTIS US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 15MG BASE/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: MILRINONE LACTATE
Proprietary Name: PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 15MG BASE/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020343
Product Number: 002
Approval Date: Aug 9, 1994
Applicant Holder Full Name: SANOFI AVENTIS US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER (MILRINONE LACTATE)
Proprietary Name: PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 15MG BASE/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020343
Product Number: 002
Approval Date: Aug 9, 1994
Applicant Holder Full Name: SANOFI AVENTIS US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: MILRINONE LACTATE
Proprietary Name: PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020343
Product Number: 003
Approval Date: Aug 9, 1994
Applicant Holder Full Name: SANOFI AVENTIS US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER (MILRINONE LACTATE)
Proprietary Name: PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020343
Product Number: 003
Approval Date: Aug 9, 1994
Applicant Holder Full Name: SANOFI AVENTIS US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: MILRINONE LACTATE
Proprietary Name: PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020343
Product Number: 004
Approval Date: Aug 9, 1994
Applicant Holder Full Name: SANOFI AVENTIS US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020343
Product Number: 004
Approval Date: Aug 9, 1994
Applicant Holder Full Name: SANOFI AVENTIS US LLC
Marketing Status: Discontinued
Patent and Exclusivity Information